Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 19, Issue 4, 2006, Pages 409-433

  Mitchell, Jolyon P ^a   Nagel, Mark W ^a   Nichols, Steve ^b   Nerbrink, Ola ^c  

^a TRUDELL MEDICAL INTERNATIONAL   (Canada)

^b Sanofi aventis UK   (United Kingdom)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Inhaler testing; Laser diffraction; Particle size analysis

Indexed keywords

ALCOHOL; APAFLURANE; BUDESONIDE; CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON; OLEIC ACID; SALBUTAMOL SULFATE;

ACCURACY; AEROSOL; ANALYTIC METHOD; ARTICLE; DRUG DELIVERY SYSTEM; INHALER; INTERMETHOD COMPARISON; LASER DIFFRACTION; MASS; MEASUREMENT; METERED DOSE INHALER; NEBULIZER; PARTICLE SIZE; POWDER INHALER; QUALITY CONTROL; THEORETICAL STUDY; VALIDATION PROCESS;

AEROSOLS; LASERS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; SCATTERING, SMALL ANGLE;

EID: 33846070206     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2006.19.409     Document Type: Article

References (90)

1. Swithenbank, J., J.M. Beer, D.S. Taylor, et al. 1977. A laser diagnostic technique for the measurement of droplet and particle size distribution. Prog. Astronaut. Aeronaut., 53:421-447.
2. International Standards Organization (ISO). 1999. Particle Size Analysis-Laser Diffraction Methods: Part 1: General Principles. ISO, Geneva, Switzerland.
3. Mitchell, J.P., and M.W. Nagel. 1999. Time-of-flight aerodynamic particle size analyzers: their use and limitations for the evaluation of medical aerosols. J. Aerosol Med. 12:217-240.
4. Bachalo, W.D., and M.J. Hauser. 1984. Phase Doppler spray analyzer for simultaneous measurements of drop size and velocity distributions. Opt. Eng. 23:583-590.
5. Gebhart, J. 1993. Optical direct-reading techniques: light intensity systems. In K. Willeke and P.A. Baron, eds. Aerosol Measurement: Principles, Techniques and Applications. Van Nostrand Reinhold, New York, 313-344.
6. Ward-Smith, S., R. Jones, and M. Wedd. 1999. Determination of continuous particle size distributions of concentrated sprays. Am. Lab. 31:17-21.
7. Krarup, H.G., M. Bumiller, and T. Stauffer. 2002. The Malvern Spraytec applied to pharmaceutical spray analysis. In R.N. Dalby, P.R. Byron, Peart, J., et al., eds. Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 505-508.
8. Marple, V.A., D.L. Roberts, F.J. Romay, et al. 2003. Next generation pharmaceutical impactor. Part 1: design. J. Aerosol Med. 16:283-299.
9. USP 28-NF 23. 2005. Chapter 429-Light diffraction measurement of particle size. United States Pharmacopeia (USP), Rockville, MD, 2314-2317.
10. Allen, T. 1990. Particle Size Analysis, 4th ed. Chapman and Hall, New York.
11. USP 28-NF 23. Suppl.1. 2005. Chapter 601-Physical tests and determinations: aerosols. United States Pharmacopeia (USP), Rockville, MD, 3298-3316.
12. European Pharmacopeia. Suppl. 5.1. 2005. Section 2.9.18-Preparations for inhalation: aerodynamic assessment of fine particles. European Pharmacopeia, 5th ed. Council of Europe, Strasbourg, France, 2799-2811.
13. Heyder, J., and M.U. Svartengren. 2002. Basic principles of particle behavior in the human respiratory tract. In H. Bisgaard, C. O'Callaghan and G.C. Smaldone eds. Drug Delivery to the Lung. Marcel Dekker, New York, 21-45.
14. Mitchell, J.P., and M.W. Nagel. 2003. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J. Aerosol Med. 16:341-377.
15. Federal Drug Administration. 1993. CDRH Reviewer Guidance for Nebulizers, Metered Dose Inhalers, Spacers and Actuators. FDA, Rockville, MD. Available at: www.fda.gov/cdrh/ode/784.html. Accessed September 15, 2006.
16. Federal Drug Administration. 2002. CDER Guidance for Industry: Nasal Spray and Inhalation Solution, Suspension and Spray Drug Products-Chemistry, Manufacturing and Controls Documentation. FDA, Rockville, MD. Available at: www.fda.gov/cder/guidance/4234fnl.pdf. Accessed September 15, 2006.
17. Federal Drug Administration. 2003. CDER Draft Guidance for Industry: Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. FDA, Rockville, MD. Available at: www.fda.gov/cder/guidance/ 5383DFT.pdf. Accessed September 15, 2006.
18. European Medicines Agency. 2005. Guideline on the pharmaceutical quality of inhalation and nasal products. Committee for Medicinal Products for Human Use (CHMP). EMEA/CHMP/QWP/49313/2005- Final. London, UK. [Also published as: Health Canada. 2005. Guideline on the pharmaceutical quality of inhalation and nasal products. Health Products and Food Branch. File 06-106624-547. Ottawa, Canada.]
19. European Standard EN 13544. 2001. Respiratory Therapy Equipment. Part 1. Nebulizing Systems and Their Components. European Committee for Standardization (CEN), Brussels, Belgium.
20. Dennis, J.H., and C.A. Pieron. 2004. Quality control and standards in nebulizer performance and use. In J. Boe, R. O'Driscoll and J.H. Dennis, eds. Practical Handbook of Nebulizer Therapy. Martin Dunitz, London, 19-40.
21. Clark, A., and L. Borgström. 2002 In vitro testing of pharmaceutical aerosols and predicting lung deposition from in vitro measurements, In H. Bisgaard, C. O'Callaghan, and G.C. Smaldone, eds., Drug Delivery to the Lung. Marcel Dekker, New York, 105-142.
22. Hickey, A.J., and R.M Evans. 1996. Propellant-driven metered dose inhalers. In A.J. Hickey, ed. Inhalation Aerosols: Physical and Biological Basis for Therapy. Marcel Dekker, New York, 417-439.
23. Mitchell, J.P., and Nagel, M.W. 1999. Size analysis of a pressurized metered dose inhaler-delivered suspension formulation by the API Aerosizer time-of-flight aerodynamic particle size analyzer. J. Aerosol Med. 12:255-264.
24. Scarlett, B. 2003. Measuring and interpreting particle size distribution. Am. Pharm. Rev. 6:93-101.
25. Witt, W., and S. Rothele. Laser diffraction-unlimited? 1996. Part. Part. Syst. Charact. 13:280-286.
26. Van de Hulst, H.C. 1981. Light Scattering by Small Particles. Dover, New York.
27. Beekman, A., D. Shan, A. Ali, et al. 2005. Micrometerscale particle sizing by laser diffraction: critical impact of the imaginary component of refractive index. Pharm. Res. 22:518-522.
28. Clark, A.R. 1995. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int. J. Pharm. 115:69-78.
29. Kippax, P. 2005. Appraisal of the laser diffraction particle sizing technique. Pharm. Technol. 88-96.
30. Saveyn, H., D. Mermuys, O. Thas, et al. 2002. Determination of the refractive index of water dispersible granules for use in laser diffraction experiments. Part. Part. Syst. Charact. 19:426-432.
31. Wedd, M.W. 2003. Determination of particle size distributions using laser diffraction. Educ. Reso. Part. Technol. O32Q:1-16. Available at: www.erpt.org/032Q/Wedd-00.htm. Accessed September 15, 2006.
32. Annapraguda, A., and A. Adjei. 1996 An analysis of the Fraunhofer diffraction method for particle size distribution analysis and its application to aerosolized sprays. Int. J. Pharm. 127:219-227.
33. Merkus, H.G., J.C.M. Marijnissen, E.H.L. Jansma, et al. 1994. Droplet size distribution measurements for medical nebulizers by the forward light scattering technique (laser diffraction). J. Aerosol Sci. 25S1:319-320.
34. de Boer, A.H., D. Gjaltema, P. Hagedoorn, et al. 2002. Characterization of inhalation aerosols: a critical evaluation of cascade impactor and laser diffraction technique. Int. J. Pharm. 249:219-231.
35. Meyer, P., and N. Chigier. 1986. Dropsize measurements using a Malvern 2200 particle sizer. Atom. Spray Technol. 2:261-298.
36. Bayvel, L.P., J. Knight, and G. Robertson. 1987. Alternative model-independent inversion programme for Malvern particle sizer. Part. Part. Syst. Charact. 4:49-53.
37. Hinds, W.C. 1999. Properties, Behavior and Measurement of Airborne Particles, 2nd ed., Wiley-Interscience, New York.
38. Vecellio None, L., D. Grimbert, M.H. Becquemin, et al. 2001. Validation of a laser diffraction method as a substitute for cascade impaction in the European project for a nebulizer standard. J. Aerosol Med. 14:107-114.
39. Kwong, W.T.J., S.L. Ho, and A.L. Coates. 2000. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor. J. Aerosol Med. 13:304-314.
40. Corcoran, I.E., R. Hitron, W. Humphrey, et al. 2000. Optical measurement of nebulizer sprays: a quantitative comparison of diffraction, phase Doppler interferometry, and time-of-flight techniques. J. Aerosol Sci. 31:35-50.
41. Bohren, C.F., and D.R. Huffman. 1983. Absorption and Scattering of Light by Small Particles. John Wiley & Sons, New York.
42. de Boer, A.H., D. Gjaltema, W. Witt, et al. 2000. The use of laser diffraction technique for the characterization of the aerosol cloud from inhalation devices. In R.N. Dalby, P.R. Byron, S.J. Farr, et al., eds. Respiratory Drug Delivery VII. Serentec Press, Raleigh, NC, 585-587.
43. Kippax, P. 2005. Malvern Instruments Ltd., UK. Personal communication.
44. Mühlenweg, H. and E. D. Hirleman. 1999. Reticles as standards in laser diffraction spectroscopy. Part. Part. Syst. Charact. 16:47-53.
45. Hirleman, E.D., V. Oechsle, and N. A. Chigier. 1984 Response characteristics of laser diffraction particle size analyzers. Opt. Eng. 23:610-619.
46. Mitchell, J.P. 2000. Particle standards: their development and application. KONA Powder and Particle 18:41-59.
47. Scarlett, B., H.G. Merkus, and G.M.H. Meesters. 1990. European progress on calibration and standardization for particle sizing. In E.D. Hirleman, W.D. Bachalo, and P.E. Felton, eds., Liquid Particle Size Measurement Techniques, Volume 2. ASTM STP 1083. American Society for Testing and Materials (ASTM), Philadelphia, 9-18.
48. Burgess, D.J., E. Duffy, F. Etzler, et al. 2004. Particle size analysis. AAPS J. 6:article 20. Available at: www.aapsj.org/. Accessed September 15, 2006.
49. Mitchell, J.P., and M.W. Nagel. 2004. Particle size analysis of aerosols from medicinal inhalers. KONA Powder and Particle 22:32-65.
50. Mitchell, J.P., M.W. Nagel, S.L. Bates, et al. 2003. An in vitro study to investigate the use of a breath-actuated small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent. Respir. Care 48:46-51.
51. Wachtel, H., and J. Ziegler. 2002. Improved assessment of inhaler device performance using laser diffraction. In R.N. Dalby, P.R. Byron, Peart, J., eds. Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 379-381.
52. Smart, J., E. Berg, O. Nerbrink, et al. 2002. Touch-spray™ technology: a comparison of the droplet size measured by cascade impaction and laser diffraction. In R.N. Dalby, P.R. Byron, Peart, J., et al., eds. Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 525-527.
53. Suman, J.D., B.L. Laube, and R. Dalby. 1999. Comparison of nasal deposition and clearance of aerosol generated by a nebulizer and an aqueous spray pump. Pharm. Res. 16:1648-1652.
54. Moslemi, P., A.R. Najafabadi, and H. Tajerzadeh. 2002. Evaluations of different parameters that affect droplet size distribution of nasal gel sprays. In R.N. Dalby, P.R. Byron, Peart, J., et al. eds. Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 619-622.
55. Wolfgang, J. 2000. A laser diffraction particle size analyzer with integrated modules for use with various inhalation drug delivery devices. In R.N. Dalby, P.R. Byron, S.J. Farr, et al., eds. Respiratory Drug Delivery VII. Serentec Press, Raleigh, NC, 535-537.
56. De Boer, A.H., D. Gjaltema, P. Hagedoorn, et al. 2002. Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. Int. J. Pharm. 249:233-245.
57. Davies, P., D. Derbyshire, T. Kotsokechagia, et al. 2003. Novel method for screening DPI and MDI formulations using experimental design and laser diffraction. In Drug Delivery to the Lungs-XIV. Aerosol Society, London, UK, 144-147.
58. Diart, V., and C. Hill. 2002. High throughput screening of early phase MDI formulations using the Sympatec Inhaler module. In Drug Delivery to the Lungs-XIII. Aerosol Society, London, UK, 119-122.
59. Jones, S.A., G.P. Martin, and M.B. Brown. 2004. Development of a rapid pre-formulation screen for HFA-suspension metered dose inhalers. In R.N. Dalby, P.R.
60. Byron, J. Peart, et al., eds. Respiratory Drug Delivery IX. Davis Healthcare International Publishers, River Grove, IL, 529-531.
61. Washington, C. 1998. Particle size analysis in inhalation therapy. In T.S. Purewal and D.J.W. Grant, eds. Metered Dose Inhaler Technology. Interpharm Press, Buffalo Grove, IL, 117-146.
62. Simons, J.K., and Stein, S.W. 2005. Replacing cascade impactors with labor saving alternatives-making the methods acceptable to the regulators. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery Europe. Davis Healthcare International Publishers, River Grove, IL, 19-27.
63. Haynes, A., M.S. Shaik, H. Krarup, et al. 2004. Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers. J. Pharm. Sci. 93:349-363.
64. Ranucci, J. 1993. Dynamic plume-particle size analysis using laser diffraction. Pharm. Technol. 16:108-114.
65. Schultz, R., O'Brien, C., Sawyer, S., et al. 2000. Factors affecting Andersen cascade impaction particle size distribution and its variability in HFA-134a metered dose inhaler formulations. In Drug Delivery to the Lungs-XI. Aerosol Society, London, UK, 123-126.
66. Smyth, H.D.C., and A.J. Hickey. 2003. Multimodal particle size distributions emitted from HFA 134a solution pressurized metered-dose inhalers. AAPS Pharm. Sci. Technol. 4:article 38.
67. Sharpe, S., J. Hart, and J. Sequeira. 2002. Effect of formulation and device on particle/droplet size distribution of metered dose inhaler (MDI) products measured by laser diffraction. In R.N. Dalby, P.R. Byron, Peart, J., et al., eds., Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 577-579.
68. Holmes, C.E., P.G. Kippax, H.E. Newell, et al. 2001. Simultaneous analysis of respirable aerosols via laser diffraction and cascade impaction. In Drug Delivery to the Lungs-XII. Aerosol Society, London, UK, 58-61.
69. Feddah, M.R., and N.M Davies. 2004. Alternative methods of particle size analysis of metered dose inhaler aerosols. J. Med. Sci. 4:63-69.
70. Smyth, H.D.C., and A.J. Hickey. 2002. Comparative particle size analysis of solution propellant driven metered dose inhalers using cascade impaction and laser diffraction. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 731-734.
71. Ding, J.Y., B.D. McVeety, D.R. Busick, et al. 2002. Correlation of particle size distribution measurements between optical and inertial impaction techniques using an ethanolic drug formulation for inhalation. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 355-358.
72. Dyksterhouse, M., T. Willbanks, and M. Roach. 2000. Comparison of cascade impaction and laser diffraction particle sizing for characterization of protein aerosols delivered from the AERx pulmonary drug delivery system. AAPS Pharm. Sci. 2:abstract 1537. Available at: www.aapsj.org/abstracts/ am_abstracts2000.asp. Accessed September 15, 2006.
73. Smart, J., E. Berg, O. Nerbrink, et al. 2002. Touch-spray™ technology: a comparison of the droplet size measured by cascade impaction and laser diffraction. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 525-527.
74. Ziegler, J., and H. Wachtel. 2001. Particle size measurement techniques for pharmaceutical device development. In Drug Delivery to the Lungs-XII. Aerosol Society, London, UK, 54-57.
75. Hess, D.R. 2000. Nebulizers: principles and performance. Respir. Care 45:609-622.
76. Fink, J.B. 2000. Metered-dose inhalers, dry powder inhalers, and transitions. Respir. Care 45:623-635.
77. Nerbrink, O., M. Dahlbäck, and H.-C. Hansson. 1994. Why do medical nebulizers differ in their output and particle size characteristics? J. Aerosol Med. 3:259-276.
78. Dolovich, M.B., N.R. MacIntyre, P.J. Anderson, et al. 2000. Consensus statement: aerosols and delivery devices. Respir. Care 45:589-596.
79. Shur, J., J.K. Shute, and A. Smith. 2004. Nebulization of unfractionated heparin: a comparative study using the Sympatec Inhaler module. In Drug Delivery to the Lungs-XV. Aerosol Society, London, UK, 244-247.
80. Sommerer, K., B. Müllinger, C. Ilmberger, et al. 2004. Performance of a conditioned laser-diffraction particle sizing setup for medical nebulizers. In Drug Delivery to the Lungs-XV. Aerosol Society, London, UK, 191-194.
81. Dennis, J.H., C.A. Pieron, J. Pagels, et al. 1999. Development and application of a low flow cascade impactor to size nebulized aerosols. J. Aerosol Med. 12:134.
82. Ferron, G.A.; C. Roth, E. Sommer, et al. 1999. Differences of size distribution of jet nebulizers measured with a residue method and a light scattering device. J. Aerosol Med. 12:121.
83. Stapleton, K.W., and W.H. Finlay. 1998. Errors in characterizing nebulized particle size distributions with cascade impactors. J. Aerosol Med. 11:80-83.
84. Tronde, A., G. Baran, S. Eirefelt, et al. 2002. Miniaturized nebulization catheters: a new approach to delivery of defined aerosol doses to the rat lung. J. Aerosol Med. 15:283-296.
85. Krarup, H.G., and P.G. Kippax. 2004. Rapid screening of dry powder inhalers by laser diffraction. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery IX. Davis Healthcare International Publishers, River Grove, IL, 541-544.
86. Kippax, P.G., D.M.J. Higgs, and M. Rehman. 2002. Analysis of dry powder aerosols using laser diffraction. In Drug Delivery to the Lungs-XIII. Aerosol Society, London, UK, 153-156.
87. Malvern Instruments Ltd. 2005. The measurement of dry powder inhalers using the Malvern Spraytec. Spraytec Brochure MRK349.
88. Kublik, H., and M.T. Vidgren. 1998. Nasal delivery systems and their effect on deposition and absorption. Adv. Drug Deliv. Rev. 29:157-177.
89. Suman, J.D., B.L. Laube, T.-C. Lin, et al. 2002. Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition. Pharm. Res. 19:1-6.
90. Suman, J.D., B.L. Laube, and R. Dalby. 2002. Documenting nasal bioequivalence from in vitro characteristics to physiologic response. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds., Respiratory Drug Delivery VIII. Davis Horwood International, Raleigh, NC, 691-693.